Respiratory syncytial virus-induced cytokine production by neonatal macrophages

Clinical and Experimental Immunology

Volumn 106, Issue 3, 1996, Pages 442-446

  Tsutsumi, H ^a   Matsuda, K ^a   Sone, S ^a   Takeuchi, R ^a   Chiba, S ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Macrophages; Neonate; Respiratory syncytial virus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; HUMAN; HUMAN CELL; MACROPHAGE; NEWBORN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; UMBILICAL CORD BLOOD; VIRUS INFECTION;

EID: 0029828794     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-874.x     Document Type: Article

References (25)

1. Parrott RH, Kim HW, Arrobio JO, Hodes DS, Murphy BR, Brandt CD, Camargo E, Chanock RM. Epidemiology of respiratory syncytial virus infection in Washington D.C. 2.Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 1973; 98:289-300.
2. Pringle BC. Paramyxoviruses and diseases. In: Russell WC, Almond JW, eds. Molecular basis of virus disease. Cambridge:Cambridge University Press, 1987: 51-90.
3. Collins PL, McIntosh K, Chanock RM. Respiratory syncytial virus. In: Fields BN, Knipe DM, eds. Fields' virology, 3rd edn. New York: Raven Press, 1996: 1313-51.
4. Richardson LS, Yolken RH, Belshe RB, Camargo E, Kim HW, Chanock RM. Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection. Infect Immun 1978: 20:660-4.
5. McIntosh K, Masters HB, Orr I, Chao RK, Barkin RM. The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis 1978; 138:24-32.
6. Kaul TN, Welliver RC, Wong DT, Udwadia RA, Riddlesberger K, Ogra PL. Secretory antibody response to primary and secondary infection with respiratory syncytial virus infection. Am J Dis Child 1981; 135:1013-6.
7. Murphy BR, Ailing DW, Snyder MH et al. Effect of age and preexisting antibody of serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol 1986; 24:894-8.
8. Murphy BR, Graham BS, Prince GA, Walsh EE, Chanock RM, Karzon DT, Wright PF. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol 1986; 23:1009-14.
9. Yamazaki H, Tsutsumi H, Matsuda K, Nagai K, Ogra PL, Chiba S. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. J Gen Virol 1994; 75:2115-9.
10. Roberts NJ, Prill AH, Mann TN. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. J Exp Med 1986; 163:511-9.
11. 2. Am J Physiol 1990; 259:L396-L402.
12. Becker S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6 and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991; 147:4307-12.
13. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, Becker S. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995; 171:584-92.
14. Matsuda K, Tsutsumi H, Okamoto Y, Chiba S. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretion of infants and children during infection with respiratory syncytial virus. Clin Diag Lab Immunol 1995; 2:322-4.
15. Li CY, Lam KW, Yam LT. Esterases in human leukocytes. J Histochem Cytochem 1973; 21:1-12.
16. Matsuda K, Tsutsumi H, Sone S, Yoto Y, Oya K, Okamoto Y, Ogra PL, Chiba S. Characteristics of IL-6 and TNF-α production by respiratory syncytial virus-infected macrophages in the neonate. J Med Virol 1996; 48:199-203.
17. Fattorini L, Li B, Piersimoni C et al. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikasin, against Mycobacterium avium. Antimicrob Agents Chemother 1995; 39:680-5.
18. Okamoto Y, Kudo K, Ishizawa K et al. Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. J Infect Dis 1993; 168:1277-81.
19. Zhang M, Gately MK, Wang E, Gong J, Wolf SF, Lu S, Modlin RL, Barnes PF. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994; 93:1733-9.
20. D'Andrea A, Rengaraju M, Valiante NM et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992; 176:1387-98.
21. Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 1993; 265(Lung Cell Mol Physiol 9):L472-8.
22. Haskill S, Johnson C, Eierman D, Becker S, Warren K. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol 1988; 140:1690-4.
23. Thornberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1 processing in monocytes. Nature 1992; 356:768-74.
24. Trinchieri G. Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4008-27.
25. Chonmaitree T, Roberts NJ, Douglas RG, Hall CB, Simons RL. Interferon production by human mononuclear leukocytes: difference between respiratory syncytial virus and influenza viruses. Infect Immun 1981; 32:300-3.